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Background: Although dental care settings provide an exceptional opportunity to reach smokers and provide brief
cessation advice and treatment to reduce oral and other tobacco-related health conditions, dental care providers
demonstrate limited adherence to evidence-based guidelines for treatment of tobacco use and dependence.
Methods/Design: Guided by a multi-level, conceptual framework that emphasizes changes in provider beliefs and
organizational characteristics as drivers of improvement in tobacco treatment delivery, the current protocol will use
a cluster, randomized design and multiple data sources (patient exit interviews, provider surveys, site observations,
chart audits, and semi-structured provider interviews) to study the process of implementing clinical practice
guidelines for treating tobacco dependence in 18 public dental care clinics in New York City. The specific aims
of this comparative-effectiveness research trial are to: compare the effectiveness of three promising strategies for
implementation of tobacco use treatment guidelines—staff training and current best practices (CBP), CBP + provider
performance feedback (PF), and CBP + PF + provider reimbursement for delivery of tobacco cessation treatment
(pay-for-performance, or P4P); examine potential theory-driven mechanisms hypothesized to explain the comparative
effectiveness of three strategies for implementation; and identify baseline organizational factors that influence the
implementation of evidence-based tobacco use treatment practices in dental clinics. The primary outcome is change
in providers’ tobacco treatment practices and the secondary outcomes are cost per quit, use of tobacco cessation
treatments, quit attempts, and smoking abstinence.
Discussion: We hypothesize that the value of these promising implementation strategies is additive and that
incorporating all three strategies (CBP, PF, and P4P) will be superior to CBP alone and CBP + PF in improving delivery of
cessation assistance to smokers. The findings will improve knowledge pertinent to the implementation, dissemination,
and sustained utilization of evidence-based tobacco use treatment in dental practices.
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Evidence-based approaches for the treatment of tobacco
dependence exist
The 2008 United States (US) Public Health Service (PHS)
Guideline, Treating Tobacco Use and Dependence, pro-
vides strong evidence that provider delivery of tobacco de-
pendence treatment, including cessation pharmacotherapy
and brief counseling, can produce significant and sus-
tained reductions in tobacco use and should be delivered
to all smokers seeking routine healthcare [1]. Provider ad-
herence to the PHS Guideline recommendations involves
asking all patients about tobacco use, advising smokers to
quit, assessing readiness to quit, providing cessation assist-
ance, and arranging follow-up (the so-called 5As) [1].
Inadequate adoption of evidence-based treatment
contributes to disparities in tobacco related illnesses
Despite the existence of effective tobacco dependence
treatments, inadequate adoption, particularly among low-
income and ethnic/racial minority smokers, has contrib-
uted to growing disparities in smoking prevalence and
tobacco-related illness [2-4]. Citing persistent missed op-
portunities to promote tobacco cessation, the Institute of
Medicine’s (IOM) report [5], ‘Ending the Tobacco Prob-
lem: A Blueprint for the Nation,’ called for greater efforts
to implement effective tobacco cessation interventions in
healthcare settings. These recent health policy reports
highlight the need and potential public health value of
reducing health disparities through dissemination of
evidence-based tobacco cessation interventions in health-
care delivery systems serving low-income and other high-
risk smokers [5,6].
Dental healthcare settings are an important but
underutilized venue for tobacco use treatment
Dental care settings have several advantageous features
for delivery of tobacco cessation treatment including:
broad reach with 62.8% of 18 to 64 years olds reporting
at least one annual dental visit [7]; access to patients
who do not receive other healthcare services (10% of
dental patients do not regularly see a physician) [8]; the
dental team routinely provides preventive services; and
controlled trials have demonstrated the efficacy of dental
office-based cessation interventions [9]. Moreover, den-
tal professionals have a credible role in providing to-
bacco cessation advice and treatment because of the oral
hazards of tobacco use. A recent national survey found
that 89% of dentists and 96% of dental hygienists re-
ported that treating tobacco use was an important pro-
fessional responsibility [10]. There are approximately 475
federally-funded, community or neighborhood health
centers with dental clinics and another 250 community
dental clinics throughout the US [11]. These commu-
nity dental health centers serve predominantly low-income populations known to have a high prevalence of
smoking [12]. The potential impact of implementing to-
bacco clinical practice guidelines in these public health
dental clinics is substantial [9].
Treatment of tobacco dependence in dental care settings
remains suboptimal
Although national surveys indicate that dental providers
are increasingly screening for tobacco use and offering
brief advice, full adherence to the PHS guidelines is in-
consistent with only 10% to 25% dental care providers
routinely delivering cessation assistance (e.g., cessation
pharmacotherapy prescriptions and/or referral for cessa-
tion counseling) [10,13]. These findings are consistent
with international findings demonstrating that treatment
of tobacco dependence in dental settings is lacking [14].
Dentists most often cite lack of training and inadequate
reimbursement to explain their limited provision of to-
bacco cessation interventions [15]. PHS guideline imple-
mentation is likely affected by both provider attitudes
and organizational priorities that impact provider behav-
ior [1,13,16-18].
Closing the gap between research and practice is sty-
mied by the paucity of research on systems changes
needed to implement tobacco treatment in routine dental
care. Drawing from a burgeoning implementation science
literature, including studies focusing on implementing to-
bacco cessation counseling in dental care settings [19,20],
the current research protocol will compare the cumulative
benefit of three, promising systems-level strategies: staff
training, practice facilitation and clinical reminders (CBP),
provider feedback and pay-for-performance (financial in-
centives), that have been widely endorsed by an IOM re-
port and the PHS Guidelines [1,21,22].
Staff training and clinical reminder systems (CBP)
The PHS Guideline strongly recommends staff training,
clinical reminder systems, referral pathways and other
practice supports as CBP for screening and treating to-
bacco dependence in all healthcare settings [1,16].
Performance feedback (PF)
In recent randomized trials conducted in primary medical
care settings, clinical audit and feedback with regard to to-
bacco treatment performance have been associated with a
twofold increase in providers’ adherence to cessation assist-
ance and referral to cessation quitlines [16-18,21,23-25].
The potential value of these strategies has not yet been
fully examined in dental practice. A single arm, pilot study
tested the feasibility and promise of implementing CBP
plus provider feedback in six public dental clinics in
New York City [26]. The main outcome measure—pro-
vider adherence to tobacco use treatment guidelines—
was assessed by auditing a random selection of dental
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plementation strategy. Following implementation of
CBP and PF, providers were significantly more likely to
offer advice (28% pre, 49% post), assess readiness to
quit (18% pre, 30% post), and offer assistance (7% pre,
16% post) [26,27].
Pay for performance (P4P)
P4P or providing financial incentives for meeting predeter-
mined performance goals has attracted much interest as a
strategy to improve quality of care [28,29]. The European
Workshop on Tobacco Use Prevention and Cessation for
Oral Health Professionals emphasized the importance of
appropriate compensation (incentives) of tobacco use treat-
ment [30]. Several studies have demonstrated a positive as-
sociation between P4P and adherence to recommended
tobacco use treatment [31-33], including increased referrals
to statewide tobacco quitline services [31].
Using a three-arm cluster randomized controlled trial
design, the overall objective of this protocol is to com-
pare the effectiveness of three promising implementation
strategies designed to address organizational and pro-
vider level challenges for effective treatment of tobacco de-
pendence. Guided by a multi-level, conceptual framework
that emphasizes both provider beliefs and organizational
characteristics, the trial will be conducted in 18 public den-
tal care clinics in New York City and information about
implementation outcomes and processes will be captured
with multiple data sources (patient exit interviews, pro-
vider surveys, site observations, chart audits, and semi-
structured provider interviews) in order to examine factors
that influence the implementation process.
The specific aims of this comparative effectiveness re-
search trial are to:
1. Compare the effectiveness and cost of three
promising strategies for implementation of the PHS
tobacco use treatment guidelines on dental provider
delivery of cessation assistance:
a) Staff training and CBP;
b) CBP + provider PF; and
c) CBP + PF + provider reimbursement for deliveryof tobacco cessation treatment (pay-for-
performance; P4P)2. Use a mixed-methods approach to examine potential
theory-driven mechanisms at the organizational and
provider level hypothesized to explain the comparative
effectiveness of three strategies for implementation;
3. Identify baseline organizational factors that influence
the implementation of evidence-based tobacco use
treatment practices in dental clinics.
The central hypothesis is that the value of these prom-
ising implementation strategies is additive and thatinstituting all three strategies (CBP, PF, and P4P) will be
superior to CBP alone and CBP + PF in increasing delivery
of cessation assistance to smokers. The ultimate goal is to
provide critical new knowledge to facilitate the widespread
implementation, dissemination and sustained utilization
of evidence-based tobacco use treatment strategies in den-
tal practices.Methods
Overview of study design
As shown in Figure 1, a three-arm cluster randomized con-
trolled trial will examine the tobacco treatment guideline
implementation process and compare the cost and effect-
iveness of three implementation strategies: Staff training
and CBP in implementing PHS Guidelines; CBP + PF; and
CBP + PF + pay-for-performance (provider reimbursement
for tobacco cessation treatment delivery). Guided by
Organizational Change Theory and the Theory of Planned
Behavior (TPB) [34-37], multi-level factors that facilitate or
impede the implementation process will be identified. The
primary outcome is improvement in dental provider deliv-
ery of tobacco cessation treatment. Secondary outcomes
are cost per quit, use of tobacco cessation treatments, quit
attempts and smoking abstinence. A mixed methods (sur-
vey, semi-structured interview, chart audit, site observation
and NYS Quitline referral report) approach will be used to
examine implementation processes (aim two).Conceptual framework
This study’s multi-level, conceptual framework and corre-
sponding selection of process measures are informed by
both the Organizational Change Model [37] for studying
organizational priority and practice improvements and the
Theory of Planned Behavior for understanding the role of
provider attitudes, norms, perceived behavioral control,
and intentions on provider behavior [34]. Guided by these
two complementary theoretical models and prior reviews
of the implementation science literature [35,36,38-42], the
proposed implementation strategies are hypothesized to
operate at both the individual health provider level and
the organizational level (see Figure 2).
Solberg posits that the primary organizational factors pre-
dicting implementation are organizational change capacity,
organizational priority (i.e., extent to which the organization
supports implementation of tobacco use treatment
guidelines relative to other priorities) and effective system
changes [25,37]. Implementation strategies (i.e., system
changes) are also hypothesized to influence dental pro-
vider attitudes, subjective norms, and perceived behavioral
control, all constructs from the TPB [34,43-45]. TPB is a
robust theoretical model that has been applied success-















Figure 1 Study design.
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chart reminders, practice support for referral to the Quit-
line or other local cessation programs) is hypothesized to
impact perceived behavioral control. The addition of pro-
vider performance feedback, (arm two) is hypothesized to
enhance provider adherence to the tobacco use treatment
guidelines through changes in subjective norms and atti-
tudes. Arm three, which adds financial incentives, is ex-
pected to impact the relative priority that organizations
and providers attribute to tobacco use treatment by ad-
dressing a frequently cited organizational barrier (i.e., lack
of reimbursement).
Description of intervention conditions
Table 2 summarizes the implementation strategy compo-
nents for each treatment arm.
Arm one: staff training and CBP
All dental clinic sites will receive CBP for training and
onsite technical assistance in promoting adoption of
clinical practice guidelines for treating tobacco depend-
ence. In New York state (NYS), the scope of dental prac-
tice includes tobacco cessation treatment. The CBP
tobacco use treatment protocol that will be implemented
is consistent with the PHS recommended guidelines.
The dental care team will assess smoking status, deliver
advice to quit, assess readiness to quit, provide patientFigure 2 Conceptual framework.education materials, provide a prescription for cessation
pharmacotherapy and/or make referral to the NYS Quit-
line, and document findings and treatment plan on the
chart system. In NYS, all cessation medications except
the nicotine lozenge, are covered by Medicaid and the
Quitline provides eligible clients at least a two-week sup-
ply of free nicotine patches. Details of CBP are summa-
rized as the following.
Staff training
All clinical (i.e., dentists, dental hygienists, and/or dental
assistants) and support staff will be trained in the use of
the intervention protocol during a one-hour, slide pres-
entation. The didactic training is based on the PHS guide-
line [1] and will include content on prescribing smoking
cessation pharmacotherapy, how to use the Refer-to-Quit
system and other local cessation referral resources, and a
review of NYS health insurance coverage for cessation
treatment. The protocol includes the provision of pharma-
cotherapy consistent with American Dental Association
(ADA) recommendations [51]. The initial training presen-
tation will be standardized and conducted by the study
co-leaders (DS/JO) and offered onsite at each individual
field site. To reinforce the new clinical protocol for docu-
menting and treating tobacco use, each site will receive a
30-minute booster training session approximately three
months after the initial training presentation.
Table 1 Theory-driven mechanisms hypothesized to
explain the effect of the implementation strategies
Implementation strategy Theory-driven hypothesized
mechanism(s) of change
Arm one Staff training and
current best practices (CBP)
Increases perceived behavioral control
Arm two CBP + audit and
performance feedback
(CBP + PF)
Increases perceived behavioral control
AND modifies providers’ subjective
norms and attitudes
Arm three CBP + PF + pay for
performance (CBP + PF + P4P)
Increases perceived behavioral control,
provider attitudes AND increases
organizational change priority
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The charting system is designed to remind the clinician
to ask those questions required for assessing readiness
to quit and to offer each smoker cessation advice. To en-
hance uptake and sustainability, a tobacco treatment
chart prompt will be integrated into the existing chart
system (i.e., paper or electronic). Most of the partnering
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booklets on the oral
effects of tobacco use
- Quitline wallet cards
- Report on oral health
in NYC
- Waiting room poster





7. Pay for Performance Xhealth record. Most sites already have billing codes for
treating tobacco use, and the remaining sites have agreed
to add chart documentation system and billing codes for
tobacco dependence.
Quitline referral system
Quitlines substantially increase abstinence rates com-
pared to minimal or no counseling [1]. Started in 2000,
the NYS Quitline counseled 82,776 current and former
smokers in 2012 [52]. The Refer-to-Quit program sim-
plifies the healthcare provider referral process by offer-
ing clinical practices a strategy to easily link patients to
the NYS Quitline using either a secure online website or
a pre-printed fax referral form. The Quitline makes five
attempts to reach patients within one week after receiv-
ing the fax or online referral. If the Quitline is unable to
reach a patient, a letter is sent encouraging the individ-
ual to contact the Quitline for assistance. Smoking ces-
sation counselors at the NYS Quitline provide one
proactive telephone counseling session and distribute a
two-week supply of free nicotine replacement therapy
(NRT). A list of local community referrals for high-risk
smokers needing more intensive cessation and/or psy-
chosocial services is also provided.
Tool kits
All dental providers will receive a Smoking and Oral
Health Quit Kit developed specifically for dental care
providers by the New York City Department of Health
and Mental Hygiene (NYC-DOHMH) [53]. The toolkit
contains a call to action letter from the Commissioner of
the NYC-DOHMH confirming that treating tobacco use,
including prescribing cessation medications, is within
dentists’ scope of practice, a provider resource guide for
delivery of cessation counseling, patient education book-
lets describing the oral health effects of tobacco and the
benefits of quitting, a pharmacotherapy prescribing in-
formation card tailored for dental providers, a summary
of oral health in New York City, and a waiting room
poster. In addition, our project added Fax/Refer-to-Quit
forms to facilitate referral to the NYS Quitline, and a
brief version of the PHS Guideline for Treating Tobacco
Dependence [1].
Tailored clinical pathway
After the baseline data (patient exit interviews and clinic
surveys) are collected, we will meet with each site dental
director to develop a clinical pathway for treating to-
bacco use tailored to the site’s current chart system and
staffing. The deliverable will be a workflow diagram of
the recommended clinical pathway and a detailed table
indicating which staff member is responsible for each
step in the clinical pathway. For example, we will docu-
ment who will place the clinical reminder on the charts
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advice and cessation assistance and specifics about how
the Refer-to-Quit system will be implemented in the
context of current practice. (i.e., who will help the pa-
tient complete the form and who will fax/submit the
Quitline referral forms). The new systems and tobacco
treatment clinical pathway will be presented during the
on-site, staff trainings.
Arm two: CBP + audit and PF
Chart audit and quarterly feedback reports
Clinic sites randomly assigned to arm two will also re-
ceive quarterly performance reports on provider delivery
of cessation services using chart audit procedures. The
research team will work with each of the study sites to
develop a system that will allow smokers to be readily
identified and placed in a smokers’ registry. This system
will vary depending on whether or not the site uses an
electronic or paper chart. Quarterly queries of the regis-
try by trained clinic staff will be conducted using a stan-
dardized chart audit tool to evaluate documentation of
cessation assistance. Each site will be provided and
trained on an audit and feedback protocol and the
process for disseminating feedback to individual pro-
viders. The PF report (see Appendix) will show individ-
ual and aggregated clinic performance summaries of
targeted 5As provider behaviors benchmarked against
other similar clinics and a recommended standard of
practice (80%). Quitting assistance will be demonstrated
by chart documentation of any of the following provider
behaviors: making a referral to the NYS Quitline, or
other community-based cessation program; providing
cessation counseling; and/or discussing and or prescrib-
ing cessation medications [54]. Quarterly reports will be
given to the dental director, who will be instructed to
circulate and discuss them with the field site’s dental
providers within 30 days.
Arm three: CBP + PF + financial incentive (P4P)
Pay for performance
Clinic sites randomly assigned to arm three will receive
CBP, quarterly PF reports, and financial incentives for
documenting delivery of adherence to clinical practice
guidelines. Using the same chart auditing procedures de-
scribed above, charts of all smokers will be reviewed for
documentation of cessation assistance (i.e., prescription
given for cessation medication, the provision of brief
cessation counseling and/or a referral to the NYS Quit-
line or other local cessation support programs). Sites will
receive $20 for each patient with chart documentation
of receiving tobacco cessation assistance. The P4P reim-
bursement bonus will be offered quarterly with an an-
nual cap of $5,000 per dental clinic. The P4P procedures
are guided by published work done by Roski (2003). Theincentive amount is also consistent with the current
Medicare and New York State Medicaid reimbursement
[55,56] schedule for 10 minutes of smoking cessation
counseling and represents an amount deemed appropri-
ate by members of our advisory committee representing
the ADA and the dental insurance industry.
Eligibility and recruitment of field sites
The selection of clinic sites is guided by our intent to
insure that findings will be generalizable to real-world
dental healthcare settings serving diverse population of
smokers. The trial will be conducted in partnership with
18 public health dental clinics employing at least two
full-time dentists, not fully adherent to PHS guidelines,
able to accept additional compensation if assigned to the
P4P arm and serving low-income patients in the New
York metropolitan region. For practical (cost and staff-
ing) reasons, clinic sites will be recruited in six succes-
sive waves with three sites enrolled per wave. Site
randomization will be conducted using the random per-
muted block method with stratification by clinic volume
(small, medium, large). Prior to enrollment, clinics will be
categorized as small (100 to 400 patients per week),
medium (401 to 750 patients per week) or large (>750 pa-
tients per week) based on the number of adult patients seen
per week per the dental director. Clinics whose patient vol-
ume is less than 100 patients per week will be excluded.
Matching the clusters has several practical and statistical
advantages. Of particular importance is that matching of-
fers some control for background effects (e.g., cigarette pri-
cing and other public policy changes) contemporaneous of
the current trial [57]. Baseline data collection will be com-
pleted prior to randomization. If the baseline providers’ as-
sessment reveals that the site assists more than 60% of
patients who smoke, then the clinic will be excluded and
replaced with an alternate site of similar patient volume.
Evaluation plan
The evaluation plan is intended to compare the effective-
ness of three promising strategies for implementation of
the tobacco use treatment guidelines, to examine multi-
level, theory-driven mechanisms (organizational priority,
provider beliefs) hypothesized to explain the effectiveness
of the three strategies for implementation, and finally to
identify multi-level barriers and facilitators that that may
influence the implementation of evidence-based tobacco
use treatment practices in dental care settings. Mixed
methods (i.e., site observational, interview and survey) data
will be collected from patients, providers, dental directors,
dental charts and Quitline referral data. For clarity, the as-
sessment plan is organized according to following evalu-
ation domains: primary outcomes, secondary outcomes,
process outcomes, organizational setting moderators, im-
plementation fidelity, and provider demographics.
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Primary outcome
To assess the primary outcome of provider adherence to
tobacco use treatment guidelines, we will conduct and
compare pre- and post-intervention patient exit inter-
views conducted with eligible smokers at each of the 18
clinic sites. Prior to beginning of the implementation
intervention, we will conduct 100 patient exit interviews
(n = 1,800 pre-intervention) at each clinic site. Then, after
each site has completed the planned intervention, another
independent sample of 100 smokers will complete patient
exit interviews (n = 1,800 post-intervention). Patient inter-
views conducted at the point of service are considered to
be the optimal non-observational method for measuring
provider delivery of outpatient treatment [58,59]. A modi-
fied patient exit interview (PEI) [60] will be used as a brief
patient-reported measurement tool for the assessment of
provider delivery of tobacco use screening and treatment.
A PEI index (summary) score is determined by adding the
number of tobacco treatment behaviors each patient re-
ports that the provider implemented during the most re-
cent visit. PEI index will scores range from 0 to 8. The
questions assess the full spectrum of PHS guideline rec-
ommended care (i.e., 5As). For example, patients are
asked if their provider advised them to quit, offered cessa-
tion counseling and/or discussed cessation medications.
The PEI has well-established validity as evidenced by
strong correlation with more costly audio-taped assess-
ment of physician-patient interactions (r = 0.67, p < 0.001)
and has been commonly used to accurately measure pro-
viders’ delivery of tobacco cessation assistance efforts dur-
ing office practice, and to monitor providers’ adherence to
tobacco cessation treatment guidelines in clinical trials.
Prior to and approximately nine months following each
site’s enrollment, consecutive patients will be approached
during their clinic visits by trained research study assis-
tants (RSA), to determine current smoking status and to
obtain consent for the PEI. Patient eligibility will include
those: age 18 or over; English- or Spanish-speaking;
current smokers defined as those who report smoking
within the past seven days; New York State residents; and
who have an appointment with a dentist or hygienist for
routine non-emergent care. Immediately after their dental
visit, patients will complete the PEI to assess provider ad-
herence to the PHS Guideline (5As). We expect that most
surveys will be administered using a computer tablet with
a password protected, web-based data entry portal (RED-
Cap) [61]; however, paper surveys will be available, as
needed.
Cost analysis
Following recommendations for cost assessment meth-
odology described by Ritzwoller et al., [62] research
costs (e.g., labor and other inputs associated with grantadministration, IRB approval, manuscript preparation),
and direct clinical intervention costs (e.g., dental pro-
vider time associated with counseling patients, staff
training, IT costs, reimbursement costs) will be esti-
mated. Templates have been developed to capture data
prospectively to improve accuracy and precision of cost
assessment. The NYS Quitline has estimates of their
counseling cost per quit. The costs of the medications
taken by the patients as part of their cessation attempt
(reported at the three-month telephone survey) will be
estimated. In addition, as part of the follow-up assess-
ment, patients will complete the EQ5D, which is a com-
monly used patient self-report measure of health status.
Applicable to a wide range of health conditions, this
measure provides a single index value for health status
that can be used in the clinical and economic evaluation
of healthcare.[63].
Secondary outcomes
To assess patient utilization of cessation services and
smoking abstinence, follow-up telephone interviews,
three months post-clinic visit, will be conducted with
smokers who complete the post intervention PEIs. A
standardized interview will be used to collect patient-
reported cessation outcomes including seven-day abstin-
ence and 24-hour quit attempt and use of cessation
treatment during the past three months.
Implementation process evaluation (aim two)
The process evaluation encompasses three areas: TPB
processes; Solberg’s construct of Organizational change
priority; and acceptability of and satisfaction with the
implementation strategies. The multiple data sources
(Table 3) include: surveys with participating dentists and
dental directors; de-identified data from quarterly chart
audits conducted by clinic administrative staff of clinical
documentation of tobacco treatment delivery; site obser-
vations; de-identified monthly reports from the NYS Quit-
line summarizing the number of referrals received; and
semi-structured interviews with dental clinic directors.
Dental director and provider surveys
Measures for four TPB variables (attitudes, subjective
norms, perceived behavioral control, and intentions) are
based on modifications of selected subscales from estab-
lished survey tools developed by Park [66], Amemori
[64], Francis [50] and Grimshaw et al. [48] to assess
knowledge and attitudes regarding treatment of tobacco
dependence, clinic norms, and perceived behavioral con-
trol, and intentions. We will use a modified version of
the Perceived Organizational Priority Survey [65] to as-
sess the perceived priority of tobacco use treatment at
the dental clinic. We also adapted a tool by Weiner
et al. to measure additional organizational factors that
Table 3 Evaluation data sources
Data source Tool Source Administration Variables
Primary outcome Patients Patient Exit Interview
(PEI)
[60] Baseline, nine months following
site enrollment
Provider adherence to PHS Guidelines for Treating Tobacco Dependence
Secondary outcomes Patients Patient Outcomes
Survey
Three months after post- PEI Use of tobacco treatment services, 24-hour quit attempt, Smoking abstin-





[62,63] Ongoing Costs per quit, QALY, Research and clinical intervention costs
Process outcomes Dental Providers Provider Attitudes
Survey
[42,48,50,64-66] Baseline, 4.5, and nine months
following site enrollment
Provider attitudes, norms, perceived behavioral control, intentions, perceived
organizational priority of tobacco use treatment
Provider Practice
Behaviors
[1] Baseline, 4.5 and nine months
following site enrollment
Provider adherence to PHS Guidelines for Treating Tobacco Dependence
Semi structured
Interviews
Nine months following site
enrollment
Provider attitudes and practice behaviors
Organizational
setting moderators
Dental Directors Organizational Structure
Survey














Site assessment tool 4.5 and nine months following
site enrollment
Pre and post intervention chart and referral systems, workflow
Dental Chart Chart audit form Baseline and Quarterly Documentation of adherence to tobacco use treatment guidelines
NYS Quitline Quitline referral reports Baseline and Quarterly Confirmation of changes in Quitline referral patterns
Provider
demographics
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interviews will be done after completion of the interven-
tion period with the dental director at each of the par-
ticipating dental clinics. The interviews will focus on
site-specific barriers and facilitators of strategy imple-
mentation, the process of integrating and customizing
the implementation strategy into the clinic site workflow
as well as acceptability and satisfaction.Baseline organizational characteristics (aim three)
Organizational change capacity
The Change Process Capability Questionnaire (CPCQ)
will be used to assess baseline measures of organizational
capacity to change [71]. The survey measures several do-
mains of change capacity: history of change, plans for con-
tinuous organizational refinement, ability to initiate and
sustain change, and strategies for process improvement.Organizational structure
At baseline, data on organizational variables shown to
influence implementation of provider practice guidelines
including number of full-time equivalent staff, insurance
payer mix, hospital-based or freestanding clinic, aca-
demic affiliation, clinic volume, and staff characteristics
will be collected [67-70,72]. Dental directors will complete
surveys in order to identify pre-intervention clinical sys-
tems and policies (e.g., electronic or paper chart system).Implementation fidelity
We will use several approaches to measure fidelity of the
three implementation strategies [73].Current best practices
At baseline, site observations will be conducted to assess
clinical processes and workflow (e.g., patient registration,
how referrals are handled, who currently screens pa-
tients for tobacco use) and these site observations will
be repeated at 4.5 and 9 months following site enroll-
ment. During these site visits, use of the dental chart
system and Refer-to-Quit forms will be determined. NYS
Quitline data will be used as an additional source of infor-
mation to confirm increases in referral rates in the post
intervention period. The NYS Quitline provides monthly
reports that include the number of referral forms received
by a specific site and provider. In addition, the percentage
of clinical staff members who attend the CBP initial and
booster training will be recorded.Chart audits and PF
The dental directors will be queried at three, six, and
nine months to confirm date of distribution of the quar-
terly PF reports.Pay for performance
The dental directors assigned to P4P will be also asked
at 3, 6, and 9 months to confirm receipt of the quarterly
financial incentive earmarked to performance of tobacco
treatment interventions.
Statistical considerations and analytic plan
General approach
Eighteen dental clinic sites will be recruited and randomly
assigned to one of three implementation strategies in a
cluster-randomized design. The general statistical paradigm
for assessing outcomes will be based on a Multi-Level
Model (MLM) approach [74] (also known as ‘hierarchical
linear model’) [8,32,75,76]. MLM adjusts for the clustering
effects across multiple levels (patients, providers, dental
clinics) of hierarchical data structure. Before the imple-
mentation strategies are rolled out, 100 patients per site
will be assessed through standardized PEIs to establish the
baseline level of dental provider assistance in tobacco ces-
sation. Then each site will be randomly assigned and will
receive their intervention condition for nine months. Fol-
lowing the intervention period, 100 new patients from each
site will be recruited for assessment of post-intervention
changes in provider adherence to the guidelines.
MLM approach to address the primary aim
A two-level MLM will test of the effectiveness of the im-
plementation strategies. The primary outcome is the
summary score of the PEI assessment of provider assist-
ance (score range 0 – 8). At level one, we will enter each
patient’s PEI score of dental provider assistance as a func-
tion of intervention and time (pre and post intervention),
thereby allowing each site to serve as its own pre-
implementation control, an added benefit to minimize an
order effect, (e.g., sites that enter the active implementa-
tion phase later may derive greater benefits due in part to
improved efficiency in logistics coordination) [75-77].
Additional covariates may also be included (e.g., patients’
age, gender, and education).
Statistical power and sample size considerations
Statistical power was calculated to ensure sufficient sam-
ple size to address two key components of study aims: de-
tect an omnibus effect on the primary outcome of PEI
scores across three intervention conditions, against the
null hypothesis that providers’ assistance behaviors are
equal across intervention conditions; and detect the differ-
ences in provider assistance rates (e.g., Quitline referral).
For the primary outcome of provider assistance behav-
iors, prior data from a recent clinical trial conducted to
improve treatment of tobacco dependence in primary care
was obtained [78,79]. The investigators compared Inter-
vention (a provider training and practice facilitation pro-
gram similar to ours) with Usual Care. The Intervention
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of 8.40 (SD = 1.93) versus an average of 6.24 (SD = 2.12) in
the Usual Care group, which translates to an estimated ef-
fect size of 1.02 (using the larger SD = 2.12). Using this
1.02 effect size, we estimated an 86% statistical power to
detect such an effect at a two-sided Type-I error rate of
0.01 (to control for multiple comparisons) for 18 sites
(six sites randomized to each intervention condition)
and 100 post-intervention patients per site [80].
Statistical power was also estimated for provider assist-
ance behaviors in a generalized estimating equation
(GEE) approach. Bentz et al. [23] reported that 10.5% of
providers randomized to the control condition gave ac-
tive assistance (e.g., referrals to quitlines); and 20.1% of
providers randomized to their feedback condition gave
active assistance. Roski et al. [33] reported a 31.4% ces-
sation assistance rate for sites randomized to a provider
incentive condition. Hence, provider assistance rates are
estimated to be 10%, 20%, and 30% (rounded to the near-
est decimal point) for the CBP, CBP + PF, and CBP + PF +
P4P arms, respectively. Horton’s simulation method [81]
was applied to calculate the statistical power of a logistic
GEE model. The simulated statistical power was 82% stat-
istical power to detect a 20% versus 10% difference in a
GEE model comparing CBP + PF versus CBP alone. The
corresponding statistical power for the 30% versus 20%
difference between CBP + PF + P4P and CBP + PF is 73%.
The statistical power for the larger 30% versus 10% differ-
ence between CBP + PF + P4P and CBP alone is 97%.
Other parameters in the simulations included a two-sided
Type-I error rate of 0.01 to control for multiple compari-
sons and an intra-class correlation of 0.22, in prior work
[23] that closely resembles our trial design.
Using the indicators described in the evaluation plan
(See Table 3), relevant process data describing the imple-
mentation fidelity of the intervention strategies (CBP, PF,
and PFP) will be summarized. All reporting of trial out-
comes data will be consistent with cluster randomized
CONSORT guidelines [82].
Ethical review
The Institutional Review Board (IRB) of New York
University School of Medicine is the IRB of record and
has reviewed and approved the study protocol. Memorial
Sloan-Kettering is the Data Coordinating Center and their
IRB has also reviewed and approved the study protocol.
There is much variation in the policies and procedures for
oversight of human subjects’ research among the 18
community-based, dental clinics. In those instances where
the dental clinic has an existing affiliation with either an
academic center or a private IRB, those IRBs will also pro-
vide review and approval. In those instances, where a den-
tal clinic has no affiliation with an IRB, the New York
University School of Medicine IRB will provide singleproject inclusion under their Federal Wide Assurance
agreement.
Trial status
Funded in March 2012, much progress has been made
in recruiting community-based dental clinics in New
York City, finalizing the evaluation plan, finalizing the
provider training plan, finalizing the tool kit for imple-
mentation strategies and developing the data manage-
ment plan for web-based, multi-level data collection.
Baseline data collection began in March 2013 and was
completed in August 2013 for the first wave of three
clinic sites. Fifty-six dental care providers have been en-
rolled and have completed the baseline provider survey.
Four dental directors completed baseline surveys. Staff
members at the individual clinic locations have received
initial as well as booster training in CBP, and the imple-
mentation period is ongoing. Site recruitment and base-
line data collection for wave two has begun, and we
expect to enroll three additional clinic sites in the Spring
of 2014.
Discussion
Using a cluster randomized controlled trial design and a
multi-level conceptual framework combining organizational
priority and provider attitudes, norms, perceived behavioral
control and intentions, the study protocol will compare the
cost and effectiveness of three promising strategies for
implementing tobacco treatment guidelines in routine den-
tal care settings serving low-income smokers: Staff training
and CBP in implementing PHS Guidelines; CBP + provider
PF; and CBP + PF + P4P (provider reimbursement for to-
bacco cessation treatment delivery). The study builds upon
prior research [19,26] and tests practical, multi-level strat-
egies to optimize the implementation of tobacco depend-
ence treatment in dental settings.
The study is innovative in four areas: Dental practices
are underrepresented settings in studying implementa-
tion of clinical guidelines for treating tobacco depend-
ence; public dental health clinics represent a novel
channel for reaching minority and low-income popula-
tions who are at greatest risk for tobacco use; the use of
a multi-level, theoretical framework for examining pro-
vider and practice-level processes for PHS guideline im-
plementation is rare. A recent review of implementation
research found that only 10% of prior studies have pos-
tulated an explicit theoretical rationale for selection of
assessment tools and intervention development [83]. As
such, our attention to process data will provide critical
information about how the intervention works as well as
multi-level barriers and facilitators of implementation,
thus providing empirical guidance needed for future ad-
aptations essential for optimizing sustainability and dis-
semination. Finally our training and clinical assistance
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status quo of didactic continuing professional education
by implementing and evaluating enhanced systems-level
strategies to improve the delivery of tobacco treatment in
dental clinics.
Some limitations and potential pitfalls need mention.
First, although letters of support were obtained from 21
dental directors (18 plus three alternates) and several
prominent community public health stakeholders who
have pledged their commitment to recruiting additional
community-based dental practices, enrollment of dental
clinics as field sites may be challenging. Second, it is
possible that variation in implementation fidelity will be
observed. To reduce this likelihood, training and technical
assistance will be standardized and a detailed implementa-
tion fidelity measurement plan will assess whether key
implementation strategies are delivered. Any variations
or adaptations will be documented and these variables
will be included in planned analyses. Finally, unforeseen
changes in tobacco prevalence (e.g., dual tobacco use)
and tobacco policy (e.g., tobacco tax, changes in Medic-
aid reimbursement, healthcare reform) may affect im-
plementation outcomes. Data on providers’ delivery of
cessation assistance will be collected from each site
prior to enrollment. This will allow each site to serve as
their own control and thereby allow us to analyze for
any historical threats to internal validity. Despite limita-
tions, the findings have potential for high impact by
identifying best practices for implementing tobacco use
treatment in public health dental clinics and providing
key stakeholders with the data they need to make deci-
sions regarding implementation of effective tobacco de-
pendence treatment guidelines.
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